Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Plos One|July 14, 2017
Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophagesJonna Idh, Blanka Andersson, Maria Lerm, et al.
Frontiers in Pharmacology|January 26, 2023
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosisHaoyue Zhang, Yuying He, Lina Davies Forsman, et al.
Frontiers in Pharmacology|April 13, 2023
Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patientsGe Shao, Ziwei Bao, Lina Davies Forsman, et al.
Antimicrobial Agents and Chemotherapy|May 9, 2022
Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association StudyDerek Conkle-Gutierrez, Calvin Kim, Sarah M Ramirez-Busby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 DecadesLina Davies Forsman, Jerker Jonsson, Charlotta Wagrell, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2023
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment RegimensYue Zhu, Limei Zhu, Lina Davies Forsman, et al.
Plos One|July 7, 2012
Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosisJonna Idh, Mekidim Mekonnen, Ebba Abate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 4, 2020
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant TuberculosisJohanna Kuhlin, Lina Davies Forsman, Mikael Mansjö, et al.
International Journal of Antimicrobial Agents|August 15, 2024
Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosisJohanna Kuhlin, Lina Davies Forsman, Aisha Osman, et al.
BMC Research Notes|August 11, 2014
A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic settingWassihun Wedajo, Thomas Schön, Ahmed Bedru, et al.
Pageof 6